Latest Breaking News On - Edx jnce us4811161011 - Page 1 : comparemela.com

Jounce Therapeutics Inc on Monday agreed to be acquired by privately held Concentra Biosciences for $96.46 million, while spurning a merger deal with British biotech firm Redx Pharma.. | March 27, 2023

United kingdomCity ofPooja desaiJane griffithsKhushi mandowaraConcentra bioscienceLondon stock exchangeTang capital partnersUnited kingdom takeover codeChair jane griffithsJounce therapeuticsNc stock exchangePress releaseEdx jnce us4811161011